AM Study Update: Full-Spectrum Cannabis Extract for Chronic Pain
This AM Study Update covers the latest research on full-spectrum cannabis extract chronic pain treatment. The phase 3 trial of Cannabis sativa extract DKJ127 shows promising results for chronic low back pain. Clinicians can use this evidence to guide…
AM Study Update: March 16, 2026
This cannabis research clinical update from March 16, 2026, summarizes 20 key studies from PubMed prioritized by clinical relevance. The update covers evidence on cannabis for chronic pain, anxiety, and adolescent health. Clinicians will find valuable…
Endocannabinoid System Clinical Research: Phase 3 Cannabis Trial Results
This article reviews the phase 3 cannabis trial chronic low back pain results 2025, highlighting the efficacy and safety of full-spectrum cannabis extract VER-01. The trial involved 820 adults and included a 12-week double-blind phase with long-term…
AM Study Update: March 11, 2026
This AM Study Update highlights cannabis clinical research 2026 with 20 prioritized studies from PubMed. The update covers clinical trials and systematic reviews relevant to cannabis medicine. Clinicians will find evidence-based insights for March 11,…
Endocannabinoid System: Phase 3 Cannabis Trial for Back Pain
This phase 3 full-spectrum cannabis extract VER-01 back pain trial evaluated 820 adults with chronic low back pain over 12 weeks. The study demonstrated meaningful pain reduction and a favorable safety profile. These results support further consideration…
Cannabinoid Clinical Trials: Full-Spectrum Cannabis for Back Pain
This phase 3 trial evaluated the full-spectrum cannabis extract for chronic low back pain in 820 adults. The study showed pain reduction and sustained benefits over 12 months. Full-spectrum cannabis extract offers a promising option for patients with…
VER-01 Cannabis Extract: Phase 3 Trial for Chronic Back Pain
The VER-01 cannabis extract clinical trial evaluated 820 adults with chronic low back pain in a rigorous phase 3 study. Results demonstrated significant pain reduction and a favorable safety profile. This trial adds important clinical evidence for…
Endocannabinoid System & Cannabis for Chronic Back Pain Trial
This phase 3 full-spectrum cannabis extract trial evaluated VER-01 for chronic low back pain in 820 adults. The study demonstrated significant pain reduction and good tolerability. These results support the potential of cannabis extract as an alternative…
Medical Cannabis Evidence-Based Care: Phase 3 Trial Results
This phase 3 cannabis trial chronic low back pain study evaluated the full-spectrum cannabis extract VER-01 in 820 adults. The trial demonstrated significant pain reduction over 12 weeks with sustained effects. These results provide important evidence…